2024-08-012025-07-312025-07-31false10294283Paraesthetic Surgical Limited2026-04-1686220falseiso4217:GBPxbrli:pure102942832024-07-31102942832025-07-31102942832024-08-012025-07-31102942832023-07-31102942832024-07-31102942832023-08-012024-07-3110294283bus:SmallEntities2024-08-012025-07-3110294283bus:AuditExempt-NoAccountantsReport2024-08-012025-07-3110294283bus:AbridgedAccounts2024-08-012025-07-3110294283bus:PrivateLimitedCompanyLtd2024-08-012025-07-3110294283core:WithinOneYear2025-07-3110294283core:AfterOneYear2025-07-3110294283core:WithinOneYear2024-07-3110294283core:AfterOneYear2024-07-3110294283core:ShareCapital2025-07-3110294283core:SharePremium2025-07-3110294283core:RevaluationReserve2025-07-3110294283core:OtherReservesSubtotal2025-07-3110294283core:RetainedEarningsAccumulatedLosses2025-07-3110294283core:ShareCapital2024-07-3110294283core:SharePremium2024-07-3110294283core:RevaluationReserve2024-07-3110294283core:OtherReservesSubtotal2024-07-3110294283core:RetainedEarningsAccumulatedLosses2024-07-3110294283core:LandBuildings2025-07-3110294283core:PlantMachinery2025-07-3110294283core:Vehicles2025-07-3110294283core:FurnitureFittings2025-07-3110294283core:OfficeEquipment2025-07-3110294283core:NetGoodwill2025-07-3110294283core:IntangibleAssetsOtherThanGoodwill2025-07-3110294283core:ListedExchangeTraded2025-07-3110294283core:UnlistedNon-exchangeTraded2025-07-3110294283core:LandBuildings2024-07-3110294283core:PlantMachinery2024-07-3110294283core:Vehicles2024-07-3110294283core:FurnitureFittings2024-07-3110294283core:OfficeEquipment2024-07-3110294283core:NetGoodwill2024-07-3110294283core:IntangibleAssetsOtherThanGoodwill2024-07-3110294283core:ListedExchangeTraded2024-07-3110294283core:UnlistedNon-exchangeTraded2024-07-3110294283core:LandBuildings2024-08-012025-07-3110294283core:PlantMachinery2024-08-012025-07-3110294283core:Vehicles2024-08-012025-07-3110294283core:FurnitureFittings2024-08-012025-07-3110294283core:OfficeEquipment2024-08-012025-07-3110294283core:NetGoodwill2024-08-012025-07-3110294283core:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3110294283core:ListedExchangeTraded2024-08-012025-07-3110294283core:UnlistedNon-exchangeTraded2024-08-012025-07-3110294283core:MoreThanFiveYears2024-08-012025-07-3110294283core:Non-currentFinancialInstruments2025-07-3110294283core:Non-currentFinancialInstruments2024-07-3110294283dpl:CostSales2024-08-012025-07-3110294283dpl:DistributionCosts2024-08-012025-07-3110294283core:LandBuildings2024-08-012025-07-3110294283core:PlantMachinery2024-08-012025-07-3110294283core:Vehicles2024-08-012025-07-3110294283core:FurnitureFittings2024-08-012025-07-3110294283core:OfficeEquipment2024-08-012025-07-3110294283dpl:AdministrativeExpenses2024-08-012025-07-3110294283core:NetGoodwill2024-08-012025-07-3110294283core:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3110294283dpl:GroupUndertakings2024-08-012025-07-3110294283dpl:ParticipatingInterests2024-08-012025-07-3110294283dpl:GroupUndertakingscore:ListedExchangeTraded2024-08-012025-07-3110294283core:ListedExchangeTraded2024-08-012025-07-3110294283dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-08-012025-07-3110294283core:UnlistedNon-exchangeTraded2024-08-012025-07-3110294283dpl:CostSales2023-08-012024-07-3110294283dpl:DistributionCosts2023-08-012024-07-3110294283core:LandBuildings2023-08-012024-07-3110294283core:PlantMachinery2023-08-012024-07-3110294283core:Vehicles2023-08-012024-07-3110294283core:FurnitureFittings2023-08-012024-07-3110294283core:OfficeEquipment2023-08-012024-07-3110294283dpl:AdministrativeExpenses2023-08-012024-07-3110294283core:NetGoodwill2023-08-012024-07-3110294283core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3110294283dpl:GroupUndertakings2023-08-012024-07-3110294283dpl:ParticipatingInterests2023-08-012024-07-3110294283dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3110294283core:ListedExchangeTraded2023-08-012024-07-3110294283dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3110294283core:UnlistedNon-exchangeTraded2023-08-012024-07-3110294283core:NetGoodwill2025-07-3110294283core:IntangibleAssetsOtherThanGoodwill2025-07-3110294283core:LandBuildings2025-07-3110294283core:PlantMachinery2025-07-3110294283core:Vehicles2025-07-3110294283core:FurnitureFittings2025-07-3110294283core:OfficeEquipment2025-07-3110294283core:AfterOneYear2025-07-3110294283core:WithinOneYear2025-07-3110294283core:ListedExchangeTraded2025-07-3110294283core:UnlistedNon-exchangeTraded2025-07-3110294283core:ShareCapital2025-07-3110294283core:SharePremium2025-07-3110294283core:RevaluationReserve2025-07-3110294283core:OtherReservesSubtotal2025-07-3110294283core:RetainedEarningsAccumulatedLosses2025-07-3110294283core:NetGoodwill2024-07-3110294283core:IntangibleAssetsOtherThanGoodwill2024-07-3110294283core:LandBuildings2024-07-3110294283core:PlantMachinery2024-07-3110294283core:Vehicles2024-07-3110294283core:FurnitureFittings2024-07-3110294283core:OfficeEquipment2024-07-3110294283core:AfterOneYear2024-07-3110294283core:WithinOneYear2024-07-3110294283core:ListedExchangeTraded2024-07-3110294283core:UnlistedNon-exchangeTraded2024-07-3110294283core:ShareCapital2024-07-3110294283core:SharePremium2024-07-3110294283core:RevaluationReserve2024-07-3110294283core:OtherReservesSubtotal2024-07-3110294283core:RetainedEarningsAccumulatedLosses2024-07-3110294283core:NetGoodwill2023-07-3110294283core:IntangibleAssetsOtherThanGoodwill2023-07-3110294283core:LandBuildings2023-07-3110294283core:PlantMachinery2023-07-3110294283core:Vehicles2023-07-3110294283core:FurnitureFittings2023-07-3110294283core:OfficeEquipment2023-07-3110294283core:AfterOneYear2023-07-3110294283core:WithinOneYear2023-07-3110294283core:ListedExchangeTraded2023-07-3110294283core:UnlistedNon-exchangeTraded2023-07-3110294283core:ShareCapital2023-07-3110294283core:SharePremium2023-07-3110294283core:RevaluationReserve2023-07-3110294283core:OtherReservesSubtotal2023-07-3110294283core:RetainedEarningsAccumulatedLosses2023-07-3110294283core:AfterOneYear2024-08-012025-07-3110294283core:WithinOneYear2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:CostValuation2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-012025-07-3110294283core:Non-currentFinancialInstrumentscore:CostValuation2025-07-3110294283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-07-3110294283core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3110294283core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3110294283core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3110294283bus:Director12024-08-012025-07-3110294283bus:Director22024-08-012025-07-31

Paraesthetic Surgical Limited

Registered Number
10294283
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2025

Paraesthetic Surgical Limited
Company Information
for the year from 1 August 2024 to 31 July 2025

Directors

Lohana, Parkash, Dr
Lohana, Rekha, Dr

Registered Address

10 Queensway
Lincoln
LN2 4AH

Registered Number

10294283 (England and Wales)
Paraesthetic Surgical Limited
Balance Sheet as at
31 July 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets37,5763,223
7,5763,223
Current assets
Debtors41,446,7061,069,653
Cash at bank and on hand24,50113,040
1,471,2071,082,693
Creditors amounts falling due within one year(215,000)(119,445)
Net current assets (liabilities)1,256,207963,248
Total assets less current liabilities1,263,783966,471
Net assets1,263,783966,471
Capital and reserves
Called up share capital100100
Profit and loss account1,263,683966,371
Shareholders' funds1,263,783966,471
The financial statements were approved and authorised for issue by the Board of Directors on 16 April 2026, and are signed on its behalf by:
Lohana, Parkash, Dr
Director
Registered Company No. 10294283
Paraesthetic Surgical Limited
Notes to the Financial Statements
for the year ended 31 July 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20252024
Average number of employees during the year01
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 August 246,804
Additions7,073
At 31 July 2513,877
Depreciation and impairment
At 01 August 243,582
Charge for year2,719
At 31 July 256,302
Net book value
At 31 July 257,576
At 31 July 243,223
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables58,74430,481
Other debtors143,061273,883
Total201,805304,364
Included within Debtors Due Within One Year is £273,834 (2024 nil) relating to directors loan accounts which were repaid after the year end.